NCT04817150

Brief Summary

The aim is to compare proximate and remote results of 3D and conventional 2D laparoscopic interventions in terms of efficacy and safety in treatment of symptomatic rectocele and rectal prolapse. This is a prospective randomized comparative study in parallel groups conducted in single Colorectal unit. Inclusion criteria: female patients with stage 3 rectocele (3-4 POP-Q \[pelvic organ prolapse quantification\] grade) and/or full-thickness rectal prolapse. Intervention - laparoscopic ventral rectopexy. The primary outcome is objective cure rate of pelvic prolapse. Secondary outcomes include obstructive defecation and incontinence symptoms according to Wexner and Cleveland Clinic scales, and satisfaction according to Patient Global Impression of Improvement questionnaire. Operative times, intraoperative blood loss, length of hospital stay, postop pain severity, urinary incontinence, as well as surgical and mesh complications are also assessed. The specific point of interest in this study is surgeon's tiredness after the operation assessed with Profile of Mood States questionnaire.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2021

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

March 19, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 26, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

April 19, 2021

Status Verified

March 1, 2021

Enrollment Period

1.2 years

First QC Date

March 19, 2021

Last Update Submit

April 15, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • objective cure rate

    objective cure rate according to clinical POP-Q assesment

    12 months postop

Secondary Outcomes (3)

  • obstructive defecation cure

    12 months postop

  • incontinence cure

    12 months postop

  • patient's satisfaction

    12 months postop

Other Outcomes (8)

  • intraoperative blood loss

    intraoperatively

  • length of hospital stay

    through study completion, an average of 1 year

  • postop pain severity

    24 hours postop

  • +5 more other outcomes

Study Arms (2)

3D-laparoscopy

EXPERIMENTAL

patients who underwent 3D laparoscopic ventral rectopexy

Procedure: Laparoscopic ventral mesh rectopexy

2D-laparoscopy

ACTIVE COMPARATOR

patients who underwent conventional 2D laparoscopic ventral rectopexy

Procedure: Laparoscopic ventral mesh rectopexy

Interventions

Conventional laparoscopic ventral mesh rectopexy, as first described by D'Hoore

2D-laparoscopy3D-laparoscopy

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • stage 3 rectocele (3-4 POP-Q grade) and/or full-thickness rectal prolapse
  • age 18-70 y.o.

You may not qualify if:

  • severe concomitants chronic diseases (American Society of Anesthesiologists class III - IV),
  • ongoing oncological diseases,
  • ongoing hematological diseases,
  • ongoing inflammatory diseases of the colon and pelvic organs,
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Private Healthcare Institution Clinical Hospital "RGD-Medicine" Rostov-on-Don"

Rostov-on-Don, 344010, Russia

RECRUITING

MeSH Terms

Conditions

RectoceleProlapseRectal Prolapse

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPelvic Organ Prolapse

Central Study Contacts

Anastasiya Golovina

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Outcomes are assessed by 2 independent blinded coloproctologists
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: a prospective randomized comparative study in parallel groups
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 19, 2021

First Posted

March 26, 2021

Study Start

March 10, 2021

Primary Completion

June 1, 2022

Study Completion

July 1, 2022

Last Updated

April 19, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations